CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Merion Inc Company Snapshot
Merion Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Merion Inc with three other companies in this sector in the United States: Ibio, Incorporation (2018 sales of $444,000.00 ), Acura Pharmaceuticals, Inc. ($410,000.00 ), and Oasmia Pharmaceutical AB ($382,593.37 of which 75% was Royalty revenues).

Sales Analysis. Merion Inc reported sales of $379,026.00 for the year ending December of 2018. This represents a sharp decrease of 50.1% versus 2017, when the company's sales were $760,172.00 .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Merion Inc
  Stock Performance Chart for Merion Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/24/2020): .53
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks n/a  
4 Weeks n/a   52 Weeks -34.3%  
 
Merion Inc Key Data:
  Ticker: EWLU Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 379,026
(Year Ending Jan 2019).
Employees: 14
  Currency: U.S. Dollars Market Cap: 93,223,247
  Fiscal Yr Ends: December Shares Outstanding: 177,264,208
  Share Type: Ordinary Closely Held Shares: 101,969,512
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.